NASDAQ: AGMBAgomab Therapeutics Nv Stock Ownership - Who owns Agomab Therapeutics Nv?
Insider buying vs selling
Have Agomab Therapeutics Nv insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| David R. Epstein | Director | 2026-10-21 | 5,000 | $8.90 | $44.50kBuy |
| David R. Epstein | Director | 2026-10-21 | 5,000 | $8.86 | $44.30kBuy |
| David R. Epstein | Director | 2026-10-08 | 5,000 | $8.90 | $44.50kBuy |
| Pierre Thadee Victor Kemula | CFO | 2026-10-06 | 5,000 | $8.57 | $42.85kBuy |
| Pierre Thadee Victor Kemula | CFO | 2026-10-06 | 2,000 | $8.54 | $17.08kBuy |
| Tim Jasper Knotnerus | CEO | 2026-10-06 | 5,000 | $8.70 | $43.50kBuy |
| David R. Epstein | Director | 2026-10-06 | 5,000 | $8.70 | $43.50kBuy |
| Pierre Thadee Victor Kemula | CFO | 2026-10-06 | 3,000 | $8.67 | $26.01kBuy |
| Tim Jasper Knotnerus | CEO | 2026-10-05 | 6,000 | $8.48 | $50.88kBuy |
| David R. Epstein | Director | 2026-10-05 | 5,000 | $8.57 | $42.85kBuy |
AGMB insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when AGMB insiders and whales buy or sell their stock.
AGMB Shareholders
What type of owners hold Agomab Therapeutics Nv stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Tim Jasper Knotnerus | 0.19% | 90,611 | $776.54k | Insider |
| David R. Epstein | 0.05% | 25,000 | $214.25k | Insider |
| Pierre Thadee Victor Kemula | 0.02% | 10,000 | $85.70k | Insider |
| Eqt Fund Management Sa Rl | 0.01% | 5,142 | $44.07k | Institution |
| Eqtrlx | 0.01% | 5,142 | $44.07k | Institution |
| Sanofi | 0.01% | 2,783 | $23.85k | Institution |
| Redmil | 0.01% | 2,734 | $23.43k | Institution |
| Redmile Group LLC | 0.01% | 2,733 | $23.42k | Institution |
| Cormorant Asset Management LP | 0.01% | 2,465 | $21.13k | Institution |
| Cormor | 0.01% | 2,465 | $21.13k | Institution |
AGMB vs Biotech Stocks
Agomab Therapeutics Nv Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.